COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,878 Articles (22,568 medRxiv, 8,310 bioRxiv)

Most recent first Previous |  Page 2031: Articles 20301-20310  | Next

An evolutionary analysis of the SARS-CoV-2 genomes from the countries in the same meridian
Mastriani, E., Rakov, A. V., Liu, S.-L.
10.1101/2020.11.12.380816 — Posted: 2020-11-13
The Preclinical Inhibitor GS441524 in Combination with GC376 Efficaciously Inhibited the Proliferation of SARS-CoV-2 in the Mouse Respiratory Tract
Shi, Y., Shuai, L., Wen, Z., Wang, C., Yan, Y., Jiao, Z., Guo, F., Fu, Z. F., Chen, H., Bu, Z.-G., Peng, G.
10.1101/2020.11.12.380931 — Posted: 2020-11-13
Molecular basis for a germline-biased neutralizing antibody response to SARS-CoV-2
Clark, S. A., Clark, L. E., Pan, J., Coscia, A., McKay, L. G. A., Shankar, S., Johnson, R. I., Griffiths, A., Abraham, J.
10.1101/2020.11.13.381533 — Posted: 2020-11-13
The Virucidal Efficacy of Oral Rinse Components Against SARS-CoV-2 In Vitro
Statkute, E., Rubina, A., O'Donnell, V., Thomas, D., Stanton, R. J.
10.1101/2020.11.13.381079 — Posted: 2020-11-13 Discussion: Onsite
In Vitro Activity of Itraconazole Against SARS-CoV-2
Van Damme, E., De Meyer, S., Bojkova, D., Ciesek, S., Cinatl, J., De Jonghe, S., Jochmans, D., Leyssen, P., Buyck, C., Neyts, J., Van Loock, M.
10.1101/2020.11.13.381194 — Posted: 2020-11-13
Critical care workers have lower seroprevalence of SARS-CoV-2 IgG compared with non-patient facing staff in first wave of COVID19.
Baxendale, D. H., Doffinger, R., Heeney, J. L., Wells, D., Gronlund, J., Carnell, G., Paloniemi, M., Tonks, P., CeronGutierrez, L., Sayer, A., Nathan, J., James, L., luptak, J., Grice, G. L., Ebrahimi, S., Xiong, X., Briggs, J. A., Pai, S., nadesalingham, a.
10.1101/2020.11.12.20145318 — Posted: 2020-11-13
Performance of Saliva, Oropharyngeal Swabs, and Nasal Swabs for SARS-CoV-2 Molecular Detection: A Systematic Review and Meta-analysis
Lee, R. A., Herigon, J. C., Benedetti, A., Pollock, N. R., Denkinger, C.
10.1101/2020.11.12.20230748 — Posted: 2020-11-13
SARS-CoV-2 serological tests can generate false positive results for samples from patients with chronic inflammatory diseases
Kharlamova, N., Dunn, N., Bedri, S. K., Jerling, S., Almgren, M., Faustini, F., Gunnarsson, I., Ronnelid, J., Pullerits, R., Gjertsson, I., Lundberg, K., Manberg, A., Pin, E., Nilsson, P., Hober, S., Fink, K., Fogdell-Hahn, A.
10.1101/2020.11.13.20231076 — Posted: 2020-11-13 Discussion: Offsite
For a structured response to the psychosocial consequences of the restrictive measures imposed by the global COVID-19 health pandemic: The MAVIPAN longitudinal prospective cohort study protocol.
LeBlanc, A., Baron, M., Blouin, P., Tarabulsy, G., Routhier, F., Mercier, C., Despres, J.-P., Hebert, M., De Koninck, Y., Cellard, C., Collin-Vezina, D., Cote, N., Dionne, E., Fleet, R., Gagne, M.-H., Isabelle, M., Lessard, L., Menear, M., Merette, C., Ouellet, M.-C., Roy, M.-A., Saint-Jacques, M.-C., Savard, C.
10.1101/2020.11.10.20227397 — Posted: 2020-11-13
Predictors of adverse outcome in patients with suspected COVID-19 managed in a virtual hospital setting: a cohort study
Francis, N. A., Stuart, B., Knight, M., Vancheeswaran, R., Oliver, C., Willcox, M., Barlow, A., Moore, M.
10.1101/2020.11.09.20228189 — Posted: 2020-11-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).